[Morphological changes in prolactinoma induced by bromocriptine treatment].
The structural modifications to PRL-secreting pituitary adenomas induced by medical treatment with bromocryptine are described. Whereas the consistency of the tumour diminishes after a shgort period of treatment, making surgical removal easier, it increases after a long period (years) owing to interstitial fibrosis phenomena that impede surgical removal.
Scanarini
M
M
Divisione di Neurochirurgia, Complesso Convenzionato, Ospedale-Università di Padova.
D001971:Bromocriptine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D010902:Pituitary Gland / Q000473:pathology / Q000601:surgery; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D015175:Prolactinoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D001971:Bromocriptine
Modificazioni morfologiche dei prolattinomi indotte dal trattamento con bromocriptina.